Top Menu HELP dot CONTACT US dot LOGIN  

www.leo-sarath.com // News Detailed
 
LEARN MORE ABOUT...

1-1-2009

Learn more about...

  • Eczema (arabic)
  • Eczema (english)
  • Diet Programme for Renal Failure Patients (arabic)
  • Diet Programme for Renal Failure Patients (english)
  • Psoriasis (arabic)
  • Psoriasis (english)
  • Psoriasis (romanian)
  • Renal Bone Disease. How does it work? (arabic)
  • Renal Bone Disease. How does it work? (english)
  • Bone Metabolism in Renal Failure Patients (arabic)
  • Bone Metabolism in Renal Failure Patients (english)
  • Venous Thromboembolism (arabic)
  • Venous Thromboembolism (english)
  • General information for dialysis patients
  • Instructions for the patients - Daivonex® Scalp Solution
  • Instructions for the patients - Daivonex® Adult Prescribing Guide
  • Coagulation in Haemodialysis - innohep® in Haemodialysis
  • Experts discussions on TV - Eczema
  • Experts discussions on TV - Osteoporosis
  • Experts discussions on TV - Psoriasis
  • Experts discussions on TV - Psoriasis Treatment
  • Experts discussions on TV - Renal
  • Making a difference


Back

For additional information or comments please contact: 

Mrs. Evie Smyrnopoulou 
IT/Web Coordinator 

evie.smyrnopoulou@leo-pharma.com 

  
 

Login to Restricted Web Area
Email:
Password:
 
 
News
12-11-2009 - LEO Pharma Completes Peplin Acquisition
 Danish LEO Pharma has gained additional ground in the US after finalising the agreement to acquire Australian-US Peplin, Inc. Read More

1-10-2009 - LEO Pharma acquires own portfolio in the US
LEO Pharma A/S, a world leader in treatment of dermatological diseases, has re-acquired the US-rights to the company’s psoriasis portfolio and dermatology pipeline from the previous partner in the US, Warner Chilcott. The transaction sum is set at... Read More

1-1-2009 - LEARN MORE ABOUT...
 Patient Educational Material Read More
SITEMAP Disclaimer Privacy Policy
LEO Pharmaceutical Products Sarath LTD . 5, Himaras street . 3rd floor . GR-151 25 Marousi . Athens . Greece. Tel: +30 210 9954545 . Fax: +30 210 9940565 .
E-mail: leo.roa@leo-pharma.com